Today’s guest post comes from Shawn Seamans, President of McKesson Life Sciences.
Shawn discusses the channel and commercialization complexities associated with launching and managing specialty medications. He then outlines McKesson Life Sciences, a business that brings together McKesson's multiple solutions for connecting biopharma companies, providers, pharmacies and payers. These solutions also help patients access their therapies.
To learn more, visit McKesson Life Sciences or email LifeSciences@mckesson.com.
Read on for Shawn’s insights.
Read more »
Source: Post feed
